Panacea
Human physiology is a limiting factor in the operational readiness of the United States Department of Defense.
When the human body is damaged or a physiological system is not functioning optimally, interventions are required to help mend the injury or support continued performance.
DARPA seeks to develop new technological approaches in medicinal chemistry and systems pharmacology to expand the druggable proteome and discover new therapeutic tools in the areas of soft tissue pain/inflammation and metabolic stress that limit optimal physiological function..
This new platform technology will directly address needs within the Department of Defense to support the unique physiological demands of the warfighter and provide proof-of-concept for novel drug discovery and development pipelines.
When the human body is damaged or a physiological system is not functioning optimally, interventions are required to help mend the injury or support continued performance.
DARPA seeks to develop new technological approaches in medicinal chemistry and systems pharmacology to expand the druggable proteome and discover new therapeutic tools in the areas of soft tissue pain/inflammation and metabolic stress that limit optimal physiological function..
This new platform technology will directly address needs within the Department of Defense to support the unique physiological demands of the warfighter and provide proof-of-concept for novel drug discovery and development pipelines.
Agency: Department of Defense
Office: DARPA - Biological Technologies Office
Estimated Funding: $4,500,000
Office: DARPA - Biological Technologies Office
Estimated Funding: $4,500,000
Obtain Full Opportunity Text:
FedBizOpps Announcement
Additional Information of Eligibility:
All responsible sources capable of satisfying the Government's needs may submit a proposal that shall be considered by DARPA.
See the Eligibility Information section of the BAA for more information.
Full Opportunity Web Address:
https://www.fbo.gov/index?s=opportunity&mode=form&id=09d21e8933de69b90507c26b405dc856&tab=core&_cview=1
Contact:
Agency Email Description:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Agency Email:
Date Posted:
2018-12-10
Application Due Date:
Archive Date:
2019-03-24
Social Entrepreneurship
Spotlight
Rwanda as Social Entrepreneur Fund Beneficiary
The Republic of Rwanda has been picked as one of the six African countries as beneficiaries for a new fellowship fund program designed at supporting social entrepreneurs in tackling issues on food security.
Learn How to Identify and Avoid Grant Scams
